TREACE MED CONCEPTS INC's ticker is TMCI and the CUSIP is 89455T109. A total of 77 filers reported holding TREACE MED CONCEPTS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42 | +740.0% | 3,225 | +1701.7% | 0.00% | – |
| Q2 2023 | $5 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q1 2023 | $5 | +25.0% | 179 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 179 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | -85.7% | 179 | -90.7% | 0.00% | – |
| Q2 2022 | $28,000 | +833.3% | 1,929 | +977.7% | 0.00% | – |
| Q4 2021 | $3,000 | -50.0% | 179 | 0.0% | 0.00% | – |
| Q2 2021 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q1 2021 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q1 2020 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | 0.0% | 179 | 0.0% | 0.00% | – |
| Q1 2019 | $6,000 | – | 179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXT CENTURY GROWTH INVESTORS LLC | 1,581,634 | $40,458,197 | 3.90% |
| Millrace Asset Group, Inc. | 72,207 | $1,847 | 1.94% |
| Perceptive Advisors | 2,217,250 | $56,717,255 | 1.64% |
| SECTORAL ASSET MANAGEMENT INC | 379,443 | $9,706,152 | 1.62% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,120,875 | $28,671,983 | 1.56% |
| EMERALD ADVISERS, LLC | 1,366,138 | $34,945,810 | 1.53% |
| FORMULA GROWTH LTD | 117,750 | $3,012,045 | 0.96% |
| OBERWEIS ASSET MANAGEMENT INC/ | 251,500 | $6,433,370 | 0.78% |
| Novo Holdings A/S | 360,000 | $9,208,800 | 0.71% |
| Intrinsic Edge Capital Management LLC | 354,585 | $9,070,284 | 0.65% |